loadpatents
name:-0.026752948760986
name:-0.015537977218628
name:-0.0082569122314453
Shirvan; Mitchell Patent Filings

Shirvan; Mitchell

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shirvan; Mitchell.The latest application filed is for "compositions and methods for treating rosacea and acne".

Company Profile
7.16.25
  • Shirvan; Mitchell - Kfar Saba IL
  • Shirvan; Mitchell - Herzliyya IL
  • SHIRVAN; Mitchell - Herzilyya IL
  • Shirvan; Mitchell - Hertzleya IL
  • Shirvan; Mitchell - Herzylia IL
  • SHIRVAN, MITCHELL - JERUSALEM IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for treating rosacea and acne
Grant 11,324,691 - Tamarkin , et al. May 10, 2
2022-05-10
Compositions And Methods For Treating Rosacea And Acne
App 20210205212 - Tamarkin; Dov ;   et al.
2021-07-08
Formation of stable cartilage
Grant 10,940,241 - Robey , et al. March 9, 2
2021-03-09
Tetracycline Management Of Egfr Inhibitor Associated Dermatoses
App 20210000842 - EINI; Meir ;   et al.
2021-01-07
Compositions and methods for treating rosacea and acne
Grant 10,849,847 - Tamarkin , et al. December 1, 2
2020-12-01
Formation Of Stable Cartilage
App 20200171215 - Robey; Pamela Gehron ;   et al.
2020-06-04
Compositions And Methods For Treating Rosacea And Acne
App 20200016068 - Tamarkin; Dov ;   et al.
2020-01-16
Tetracycline Management Of Egfr Inhibitor Associated Dermatoses
App 20190307778 - EINI; Meir ;   et al.
2019-10-10
Compositions and methods for treating rosacea and acne
Grant 10,398,641 - Tamarkin , et al. Sep
2019-09-03
Tetracycline Management Of Egfr Inhibitor Associated Dermatoses
App 20180235984 - EINI; Meir ;   et al.
2018-08-23
Compositions And Methods For Treating Rosacea And Acne
App 20180064638 - Tamarkin; Dov ;   et al.
2018-03-08
Activated leukocyte conditioned supernatant and uses for wound healing
Grant 9,439,950 - Shirvan , et al. September 13, 2
2016-09-13
Activated Leukocyte Conditioned Supernatant And Uses For Wound Healing
App 20160089420 - Shirvan; Mitchell ;   et al.
2016-03-31
Activated Leukocyte Composition And Uses For Wound Healing
App 20150352151 - SHIRVAN; Mitchell ;   et al.
2015-12-10
Activated leukocyte conditioned supernatant and uses for wound healing
Grant 9,168,287 - Shirvan , et al. October 27, 2
2015-10-27
Activated leukocyte composition and uses for wound healing
Grant 9,132,154 - Shirvan , et al. September 15, 2
2015-09-15
Activated Immunostimulatory Cell Composition for Therapy of Infection
App 20150071892 - Ginis; Irene ;   et al.
2015-03-12
Activated Immunostimulatory Cell Composition and Uses Thereof
App 20150030635 - Ginis; Irene ;   et al.
2015-01-29
Activated Leukocyte Composition and Uses For Wound Healing
App 20140004091 - Shirvan; Mitchell ;   et al.
2014-01-02
Activated leukocyte composition and uses for wound healing
Grant 8,574,902 - Shirvan , et al. November 5, 2
2013-11-05
Activated Leukocyte Conditioned Supernatant And Uses For Wound Healing
App 20130224148 - Shirvan; Mitchell ;   et al.
2013-08-29
Activated Leukocyte Composition And Uses For Wound Healing
App 20130071465 - SHIRVAN; Mitchell ;   et al.
2013-03-21
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
Grant 8,288,442 - Shirvan , et al. October 16, 2
2012-10-16
Activated Leukocyte Composition And Uses For Wound Healing
App 20120058156 - Shirvan; Mitchell ;   et al.
2012-03-08
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
App 20090281045 - Shirvan; Mitchell ;   et al.
2009-11-12
Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
App 20080152630 - Ginis; Irene ;   et al.
2008-06-26
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment of prevention of pain and/or headache disorders
App 20040204495 - Shirvan, Mitchell ;   et al.
2004-10-14
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
App 20030212142 - Shirvan, Mitchell ;   et al.
2003-11-13
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
Grant 6,555,585 - Shirvan , et al. April 29, 2
2003-04-29
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
App 20020103237 - Shirvan, Mitchell ;   et al.
2002-08-01
Compositions Containing And Methods Of Using 1-aminoindan And Derivatives Thereof And Process For Preparing Optically Active 1-aminoindan Derivatives
App 20020068839 - COHEN, SASSON ;   et al.
2002-06-06
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
App 20020052418 - Shirvan, Mitchell ;   et al.
2002-05-02
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
Grant 5,914,349 - Cohen , et al. June 22, 1
1999-06-22
Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
Grant 5,585,358 - Bialer , et al. December 17, 1
1996-12-17
Company Registrations
SEC0001727789Shirvan Mitchell

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed